Some Stem Cell Experts Want Out of Documentary After Funding Source Revealed
By Erin Allday,
San Francisco Chronicle
| 06. 15. 2019
A new documentary about stem cell therapy is being questioned by some of those who appear in it — prominent cellular scientists who say they weren’t aware of who was backing the project when they agreed to participate.
The 10-part series is set to launch online Monday. The filmmakers said they may delay the premiere because some people interviewed for the project no longer want to be involved, after learning that the movie was funded in part by for-profit stem cell providers who are under federal investigation. Some scientists said they fear the documentary may promote what they consider junk science.
A five-minute trailer for “The Healthcare Revolution” is online at the website www.healthcarerev.org, where a surprisingly deep lineup of “expert sources” in stem cells is listed along with the institutions they represent.
Among the scientists named is Dr. Maria Millan, head of the California Institute for Regenerative Medicine, the state’s stem cell funding agency. Also named are three consumer stem cell providers who have been sued by the U.S. Food and Drug Administration to stop their operations; one...
Related Articles
Flag of South Africa; design by Frederick Brownell,
image by WikimediaCommons users.
Public domain, via Wikimedia Commons
What is the legal status of heritable human genome editing (HHGE)? In 2020, a comprehensive policy analysis by Baylis, Darnovsky, Hasson, and Krahn documented that more than 70 countries and an international treaty prohibit it, and that no country explicitly permits it. Policies in some countries were non-existent, ambiguous, or subject to possible amendment, but the general rule remained, even after one...
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes that...
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...